Latest Articles
-
How Will Medtronic’s Success In The Surgical Robot Market Be Determined?
This week Medtronic (NYSE:MDT) announced that it expects to see material revenue from surgical robots in FY 2019. In this analysis, we discuss the factors which will determine how big a player can Medtronic be in this relatively new area. Co...
-
How Did Medtronic Fare In Q4’16 Earnings?
Leading medical device maker Medtronic (NYSE:MDT) posted its Q4’16 earnings on May 31st. (Fiscal years end with April.) The company got FDA approval during the quarter for its Micra transcatheter system, the world’s smallest pacemak...
-
Medtronic Earnings: Recently Launched Products And Incremental Revenues From Covidien Acquisition Help Post Strong Quarter
Leading medical device manufacturer Medtronic (NYSE:MDT) reported its Q3 fiscal 2016 earnings on March 1st. (Fiscal years end with April.) The company posted revenue growth of 6% driven by incremental revenues from Covidien acquisition and a st...
-
Medtronic’s Earnings Preview: New Product Launches And Synergies From Covidien Acquisition Likely Drove Growth In Q3’16
Leading medical device manufacturer Medtronic (NYSE:MDT) will report Q3 fiscal 2016 earnings on March 1st. (Fiscal years end with April.) We expect the company to see growth coming in from the market expansion due to new product launches and t...
-
New Products Drove Medtronic’s Q2 Revenues
Medtronic reported strong revenue growth in its fiscal 2016 second quarter results released on December 3rd. The company’s string of new products released over the past year helped boost the top line in the second quarter. The trend is expe...
-
Medtronic Earnings Preview: Medtronic Micra TPS To Drive Company’s Near Term Growth
Leading medical device manufacturer Medtronic (NYSE:MDT) will report its Q2 earnings on December 3 rd . (Fiscal years end with April.) We expect the company to see growth coming in from the increased adoption for its Transcatheter Pacing System ...
-
Can Medtronic’s Leadless Pacemaker Improve The Company’s Share In Cardiac Rhythm Management?
In a recent clinical trial, Medtronic’s ( NYSE: MDT) wireless pacemaker, the “Medtronic Micra Transcatheter Pacing System (TPS)”, was proven to be significantly more effective than current options with a high degree of efficacy. Dat...
-
Medtronic’s Growth Strategy At Work In Strong Q1 Results
Medical device manufacturer Medtronic (NYSE:MDT) posted strong revenue growth across the board in the first quarter of fiscal 2016 in its earnings release on September 3rd. The company was hammered by currency headwinds as expected, but achieved ...
-
Heavy Currency Headwinds Expected in Medtronic’s Q1 Results
Medical devices manufacturer Medtronic (NYSE:MDT) is scheduled to report its fiscal 2016 first quarter results on September 3rd. Medtronic completed the consolidation of Covidien’s acquisition last fiscal year, but significant synergies are not e...
-
Medtronic Bets Nearly Half A Billion Dollars On Transcatheter Mitral Valve Market
Earlier this week, medical devices manufacturer Medtronic (NYSE:MDT) entered into an agreement to purchase Twelve Inc., a medical device startup focused on the development of a transcatheter mitral valve replacement, for $458 million. The acquisi...
-
Medtronic’s New Product Launch Boosts Its Rather Sluggish Spinal Division
Medtronic (NYSE:MDT) is resorting to all possible means to boost growth. This includes the recently completed acquisition of Covidian, increased penetration into emerging markets, expansion of product portfolio and restructuring of initiatives, ...
-
Medtronic Reports Strong Earnings, Covidien Integration Going Well
Medtronic (NYSE: MDT) reported better-than-expected fiscal fourth quarter results on Tuesday, June 2, with operational revenue growing 7% year-over-year (y-o-y) to about $7.32 billion, on a comparable and constant currency basis. This was the fir...
-
Medtronic Likely to Meet Earnings Estimates, Driven By Robust Sales
Medical device maker Medtronic (NYSE: MDT) is scheduled to release its fourth quarter fiscal 2015 results on June 2. In the previous quarter, the company reported operational revenue growth of 7.5% year over year to about $4.32 billion. The comp...
-
Medtronic Notes: Launch of New Products In Focus
Medtronic (NYSE:MDT) continues to bring new medical innovations to the table as it received FDA clearance for several of its products recently. These include the Arctic Front Advance ST CryoAblation catheter, Zevo Anterior Cervical Plate system a...
-
Medical Devices Weekly Update: Medtronic and Boston Scientific
Last week was eventful for Medtronic (NYSE:MDT) and Boston Scientific (NYSE:BSX) within the medical device sector. Medtronic has taken significant steps to expand its Diabetes business by acquiring Diabeter, a Dutch based company, and forming a...
